Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BHVN stock hub

Biohaven Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BHVNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

BHVN

In the news

Latest news · BHVN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-333

P25 -105.6P50 -46.5P75 -3.1

ROIC-108.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BHVN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001935979
Company name	Biohaven Ltd.
Country	United States
Country code	US
Cusip	G11196105
Employees	274
Employees Change	18%
Employees Change Percent	7.03
Enterprise value	$1.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-05-04
Isin	VGG1110E1079
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$9.86
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	BHVN
Website	https://www.biohaven.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-43.63%
EV Sales Forward	197.65x
FCF yield	-40.05%
P/B ratio	11.46x
PS Forward	206.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-647.7M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	$-2.4M
ROA	-83.38
Roa5y	-84.74
ROCE	-149
ROE	-333
Roe5y	-204.7
ROIC	-108.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-48.18%
Cagr3y	-11.53%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$466.4M
Cash	$347.8M
Current Assets	$385.6M
Current Liabilities	$52.1M
Debt	$286.2M
Debt Equity	$2.21
Equity	$129.5M
Liabilities	$336.9M
Long Term Assets	$80.8M
Long Term Liabilities	$284.8M
Net Cash	$61.6M
Net Cash By Market Cap	$4.15
Net Cash Growth	-78.54%
Net Debt Equity	$-0.48
Tangible Book Value	$109.7M
Tangible Book Value Per Share	$0.73
WACC	18.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.41
Net Working Capital	$-8.3M
Quick ratio	6.68
Working Capital	$333.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.59%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-48.16%
200-day SMA	12.17
3Y total return	-30.76%
50-day SMA	9.76
50-day SMA vs 200-day SMA	50under200
All Time High	62.21
All Time High Change	-84.15%
All Time High Date	2024-03-08
All Time Low	5.54
All Time Low Change	77.98%
All Time Low Date	2022-10-03
ATR	0.72
Beta	3.31
Beta1y	0.88
Beta2y	1.57
Ch YTD	-12.67
High	9.92
High52	22.05
High52 Date	2025-05-12
High52ch	-55.28%
Low	9.36
Low52	7.48
Low52 Date	2025-11-11
Low52ch	31.82%
Ma50ch	1.05%
Premarket Change Percent	3.08
Premarket Price	$10.04
Premarket Volume	3,705
Price vs 200-day SMA	-18.95%
RSI	50.05
RSI Monthly	38.8
RSI Weekly	42.71
Sharpe ratio	-0.31x
Sortino ratio	-0.36
Total Return	-23.59%
Tr YTD	-12.67
Tr1m	6.48%
Tr1w	2.39%
Tr3m	-15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	6
Analyst Price Target Top	$26
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.78
Earnings Revenue Estimate	8,288,000x
Operating Income	$-617.2M
Price target	$29
Price Target Change	$194
Price Target Change Top	$164

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,998,998%
Float Percent	82.36%
Net Borrowing	250,000,000
Shares Insiders	10.81%
Shares Institutions	85.49%
Shares Out	150,560,990
Shares Qo Q	22.82%
Shares Yo Y	23.59%
Short Float	19.18%
Short Ratio	10.55
Short Shares	15.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-682.1M
Average Volume	1,842,269.4x
Bv Per Share	0.86
CAPEX	$-254,000
Ch1m	6.48
Ch1w	2.39
Ch1y	-48.16
Ch3m	-15
Ch3y	-30.76
Ch6m	19.37
Change	1.23%
Change From Open	2.82
Close	9.74
Days Gap	-1.54
Depreciation Amortization	10,042,000
Dollar Volume	19,509,173.5
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-617.2M
EBITDA	$-607.2M
EPS	$-5.44
F Score	2
FCF	$-594.5M
FCF EV Yield	-41.78x
FCF Per Share	$-3.95
Financing CF	617,764,000
Fiscal Year End	December
Founded	2,013
Goodwill	1,390,000
Income Tax	$1.1M
Investing CF	150,894,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	11.31
Ma150ch	-12.84%
Ma20	10.06
Ma20ch	-1.95%
Net CF	174,416,000
Open	9.59
Optionable	Yes
Position In Range	89.29
Post Close	9.86
Postmarket Change Percent	-0.3
Postmarket Price	$9.83
Ppne	58,656,000
Pre Close	9.74
Price Date	2026-05-08
Ptbv Ratio	13.53
Relative Volume	1.07x
Share Based Comp	87,585,000
Tr6m	19.37%
Us State	Connecticut
Volume	1,978,618

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BHVN pay a dividend?

Capital-return profile for this ticker.

Performance

BHVN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BHVN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+85.5%

Float: +82.4% of shares outstanding

Insider ownership

+10.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BHVN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.1

Neutral momentum band

Price vs 200-day MA

-19.0%

50/200-day relationship not available

Beta (5Y)

3.31

More volatile than the market

Sharpe ratio

-0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BHVN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BHVN stock rating?

Biohaven Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BHVN analysis?

The full report lives at /stocks/BHVN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BHVN?

The latest report frames BHVN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BHVN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.